Reata Pharmaceuticals Inc
RETADelisted Sep 26, 2023- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001358762
Reata Pharmaceuticals Inc was delisted on Sep 26, 2023; its insiders filed their last Form 4 on Sep 28, 2023; 214 institutions reported holding it in 13F filings for Q2 2023, worth $3.21B in total; no superinvestor held it.
Holders of 5% or more of RETA
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Reata Pharmaceuticals Inc, largest stake first. The change is against the holder's previous filing.
No holder currently reports owning 5% or more of Reata Pharmaceuticals Inc on Schedule 13D or 13G.
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
Schedule 13D and 13G filings on Reata Pharmaceuticals Inc, newest first.
No Schedule 13D or 13G filings on Reata Pharmaceuticals Inc are on file.
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell Reata Pharmaceuticals Inc shares.
No Form 144 notices for Reata Pharmaceuticals Inc are on file.